Back to search
FDAFDA · Food and drugs·Recall number D-0572-2020

fentaNYL 550 mcg/55 mL (10 mcg/mL) in 0.9% Sodium Chloride 55 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1274-50

Published December 11, 2019 · Recall initiated: November 12, 2019

Summary

FDA records drug Class II recall D-0572-2020, published December 11, 2019 and initiated November 12, 2019. Recalling firm: QuVa Pharma, Inc.; Status: Terminated; Lot: Lot: 10031855 Exp. 12/24/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
QuVa Pharma, Inc.
Distributor
Nationwide.
Lot
Lot: 10031855 Exp. 12/24/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was fentaNYL 550 mcg/55 mL (10 mcg/mL) in 0.9% Sodium Chloride 55 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1274-50 recalled?

Yes. FDA published recall D-0572-2020 on December 11, 2019. Reported hazard: Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

What should I do if I have this product?

Voluntary: Firm initiated · Letter